Oritavancin (LY333328)
目录号: A15771
奥利塔霉素是一种新型半合成糖肽类抗生素。2014年8月6日,美国食品和药物管理局(FDA)批准奥利塔霉素用于治疗皮肤感染。奥利塔霉素对广泛的耐药和敏感的革兰氏阳性细菌具有强大且迅速的杀菌活性,包括金黄色葡萄球菌、MRSA(耐甲氧西林金黄色葡萄球菌)、肠球菌和链球菌。
Discription | Oritavancin is a novel semisynthetic glycopeptide antibiotics. On August 6, 2014, the FDA approved oritavancin for treatment of skin infections. Oritavancin possesses potent and rapid bactericidal activity in vitro against a broad spectrum of both resistant and susceptible Gram-positive bacteria, including Staphylococcus aureus, MRSA, enterococci, and streptococci. |
---|
目录号 | A15771 |
---|---|
分子式 | C86H97Cl3N10O26 |
分子量 | 1793.1 |
CAS号 | 171099-57-3 |
SMILES | C[C@H]1[C@@H]([C@@](C[C@@H](O1)O[C@H]2[C@H]3C(=O)N[C@@H](C4=C(C(=CC(=C4)O)O)C5=C(C=CC(=C5)[C@H](C(=O)N3)NC(=O)[C@H]6C7=CC(=C(C(=C7)OC8=C(C=C2C=C8)Cl)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O[C@H]1C[C@]([C@H]([C@@H](O1)C)O)(C)NCC1=CC=C(C=C1)C1=CC=C(C=C1)Cl)OC1=C(C=C(C=C1)[C@H]([C@H](C(=O)N[C@H](C(=O)N6)CC(=O)N)NC(=O)[C@@H](CC(C)C)NC)O)Cl)O)C(=O)O)(C)N)O |
其他名称 | LY333328 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2